Katrien Oosterom
Pharmaceutical Science
C2 Pharma
Luxembourg
Biography
Katrien Oosterom is a Director Quality and Regulatory Affairs at C2 Pharma.
Research Interest
Regulatory affairs
Global
Pharmaceutical Sciences Experts
Recommended Journals
- Biomedicine Journal
- Pharmaceutical Analysis Journal
- Bioequivalence Journal
- Pharmaceutical Analysis Journal
- Pharmacovigilance Journal
- Drug Safety Journal
- Drug Metabolism Journal
- Drug safety Journal
- Clinical Trials Journal
- Community Medicine Journal
- Health Care Journal
- Forensic Toxicology Journal
- Pharmacological Reports Journal
- Pharmaceutical Regulatory Affairs Journals
- Drug Designing Journals
- Pharma research Journal
Recommended Conferences
-
13th Asian Biologics and Biosimilars Congress
July 26-27, 2019 Melbourne, Australia
Relevant Topics
- Advances in Bioavailability
- Adverse Effects
- American Health Care Systems
- Anvisa Bioequivalence
- Anvisa regulatory guidelines
- Australian Health Care Systems
- BA/BE Studies
- Bioequivalence Anticancers
- Bioequivalence Antidiabetics
- Bioequivalence Antidiuretics
- Bioequivalence Antipsychotics
- Bioequivalence Cardiovascular Products
- Bioequivalence Study Design
- Bioequivalence Study Protocols
- Biopharmaceutics
- Biosimilars
- British regulatory guidelines
- Canadian Health Care Systems
- Causality Assesment
- Clinical Cancer Trials
- Clinical Drug Trial
- Clinical Management Systems
- Clinical Pharmacovigilance
- Clinical Trials Pharmacovigilance
- Drug devices
- Drug Monitoring
- Drug Safety Survillance
- Europe Pharmacovigilance
- European Bioequivalence
- Europian Health Care Systems
- Europian regulatory guidelines
- Experimental Drug Trial
- FDA Bioequivalence
- Good Pharmacovigilance Practice
- Health Care Management Systems
- Health Information Systems
- Health Insurance Systems
- Health Polices
- Health Systems
- Health Systems Services
- In vitro Bioequivalence
- Japan Health Care Systems
- Japan Pharmacovigilance
- Japan regulatory guidelines
- Medical Billing Softwares
- Medical devices regulations
- Medical Literature
- Medical Software Companies and Software Analysis
- Medication Error
- Medication Management Services
- Observatory Health Policies
- Online Pharmacy
- Paid Clinical Trials
- Periodic Safety Update Reports
- Pharma Risk Management
- Pharmaceutical care
- Pharmaceutical Care Management
- Pharmaceutical Care Models
- Pharmaceutical Care Practice
- Pharmaceutical companies and regulatory guidelines
- Pharmaceutical ethics
- Pharmacovigilance and Risk Management
- Pharmacovigilance for Alternative Medicine
- Pharmacovigilance Regulatory Updates
- Pharmacy Education
- Pharmacy Practice
- Quality assurance in regulatory affairs
- Regulatory affairs
- Regulatory affairs for clinical trails
- Regulatory compliance
- Regulatory consulting and market analysis
- Regulatory Requirements in Bioequivalence
- Regulatory requirements of pharmaceutical products
- Regulatory services and market analysis
- UK Pharmacovigilance
- US FDA guidelines
- US Pharmacovigilance
- Veterinary Pharmacovigilance